They announced their decision to do so in a research note that was distributed to investors on Thursday.
Equities analysts at StockNews.com have begun covering shares of Baxter International (NYSE: BAX), and they did so publicly for the first time on Thursday.
The investment advice given by the company was to “hold” rather than sell the medical equipment provider’s stock.
In a report made available to the public on February 9, Baxter International (NYSE: BAX) shared its findings.
The manufacturer of medical supplies and devices reported earnings per share of $0.88 for its findings to the public.
The manufacturer of medical supplies and devices reported earnings per share of $0.88 for the quarter.
This was $0.05 less than market analysts’ consensus estimate of $0.94.
The manufacturer of medical supplies and devices also reported earnings per share for the full year of $1.01, which was $0.05 higher than the previous year. However, the revenue the company brought in for the quarter was $3.89 billion, significantly higher than the $3.77 billion analysts anticipated it would bring in.
Baxter International had a positive return on equity of 24.03%, but its net margin was negative at 16.10%.
Despite this, the return on equity was good. Compared to the current quarter, the previous quarter’s sales of the company’s products and services showed a 10.6% increase. Compared to the previous year’s results for the same period, the company was successful in generating earnings of $1.04 per share.
During the current fiscal year, Baxter International is expected to generate $2.84 per share, as stated by projections made available by equity analysts.
NYSE: opening The price of BAX on the trading floor on Thursday was $38.23.
The stock’s moving averages for the past 50 and 200 days are currently $42.79 and $50.39, respectively.
The 50-day moving average is currently higher than the 200-day moving average.
The company’s current market capitalization is $19.29 billion thanks to a price-to-earnings ratio of -7.92, a price-to-growth ratio of 2.39, and a beta value of 0.55.
Baxter International hit a low of $37.74 over the past year, while the company reached a high of $80.72 over the same period.
The current ratio to the quick ratio is 1.12; the current ratio to the quick ratio is 1.69; and the debt to equity ratio is 2.58.
In recent times, BAX has received feedback from various experts outside of the research community. On Friday, February 10, Cowen lowered their price target on shares of Baxter International from $70.00 down to $45.00 while maintaining their “outperform” rating on the stock. Raymond James lowered its rating for Baxter International from “outperform” to “market perform” in a report made public on Thursday, January 5.
Morgan Stanley lowered its price objective on Baxter International’s stock from $55.00 to $44.00 and assigned it an “equal weight” rating in a research report that was made public on February 10.
Baxter International was downgraded from a “buy” rating to a “hold” rating in a research report that was made public on Thursday, December 15.
Additionally, Deutsche Bank Aktiengesellschaft decreased its price target from $69.00 to $51.00.
Both of these changes were reflected in the company’s share price target.
Both of these alterations were carried out. Citigroup assigned a “neutral” rating to the stock and decreased its target price on Baxter International shares from $58.00 to $44.00 in a report published on Monday, February 13.
In addition, the company decreased its target price for the stock.
The advice of one financial expert is to sell the stock, while the advice of nine other analysts is to hold on to it, and the advice of three analysts is to purchase it.
Most market analysts have assigned the company a rating of “Hold,” The average price target for the company’s stock is $55.14 per share.
This data was retrieved from the Bloomberg website.
On January 17, Senior Vice President Jeanne K.
Mason sold 59,477 shares of the company’s stock, which brings us to another piece of information regarding the business.
A total of 2,658,621.90 dollars’ worth of the company’s stock was sold at an average price of $44.70 per share, which resulted in the transaction totaling $2,658,621.90.
As a result of the sale being finalized, the senior vice president now has direct control over 126,231 shares of the company, which have a value of $5,642,525.70.
If you click on this link, you will be taken to a legal filing with the SEC, giving you more information regarding the transaction.
It will take you there immediately, according to additional news concerning the company; Senior Vice President Jacqueline Kunzler sold 3,813 shares of Baxter International stock on Tuesday, February 21.
This information was reported in other news reports regarding the company.
A total of $154,426.50 worth of shares were transacted at an average price of $40.50 per share, leading to a sale volume of 154,426.50 dollars. Following the conclusion of the transaction, the senior vice president was awarded 16,725 shares in the company.
Based on the current market price, these shares have a value of approximately $677,362.50.
The Securities and Exchange Commission was given legal documents about the transaction, which were subsequently uploaded to the SEC website after being provided to the SEC.
Additionally, on January 17, Senior Vice President Jeanne K.
Mason sold 59,477 shares of the company’s stock.
A total of 2,658,621.90 dollars’ worth of the company’s stock was sold at an average price of $44.70 per share, which resulted in the transaction totaling $2,658,621.90.
As a direct result of the sale, the company’s senior vice president now directly owns 126,231 shares of the corporation.
These shares are currently trading at a price corresponding to a market value of approximately $5,642,525.70.
This is the section where you might find the disclosure associated with the sale.
The company insiders’ current ownership of the company’s stock is 0.21%.
During the most recent period, significant investors have been engaged in the buying and selling of shares in the company.
A new investment in the form of shares of Baxter International was made by CoreCap Advisors LLC during the fourth quarter of 2018, bringing the total amount of capital committed to this investment to approximately $27,000.
The Old North State Trust LLC acquired a new position at Baxter International during the third quarter of the fiscal year.
It was estimated that this new position was worth approximately $37,000. Cowa LLC increased its holdings in Baxter International by purchasing additional shares during the third quarter, bringing the total value of the company’s holdings to approximately $40,000.
During the fourth quarter of 2018, Horizon Bank, INC acquired a new interest in Baxter International shares by investing approximately $39,000 in the new interest.
This piece’s fourth and final point is that RFP Financial Group LLC spent close to $41,000 to purchase a new interest in Baxter International during the fourth quarter.
This is the point that bears the most weight and significance.
The majority of the company’s stock is owned by large financial institutions, which account for 84.84% of the total.